结果:包括三千八百fire T2D无PWH(男性78.5%,39.9 11.3岁)。中位随访4。8年(四分位间范围2.2-7.8)后,有62名参与者(1.6%)开发了T2D,对应于每1000人年的3.18(95%的浓度间隔间隔1.47-2.47-4.08)。开发T2D的参与者年龄较大(48.7 12.4 vs. 39.8 11.2岁),更有可能肥胖(22.6%vs. 7.4%),腹部肥胖(9.7%vs. 1.5%),并且比没有T2D的糖尿病家族史(32.3%vs. 19.1%)。入射T2D的AUC介于0.72(Kraege 16)和0.81(SDA,Findrisc2和Balkau)之间。敏感性在3.2%(Balkau)至67.7%(Findrisc1)之间,而特定范围在80.9%(Findrisc1)和98.3%(Balkau)之间。所有分数的阳性预测值低于20%,而负预测值高于98%。
Loos PhD 12,133,5,Susan R. Heckbert MD,PhD 134,Peter Vollenweider MD 135,Caroline Hayward PhD 136,Andrew D. Paterson MD 17,137,Kari Stefansson MD,Kari Stefansson MD,Phd 18,88 Nicholas J. Wareham PhD 22 , Cornelia M. van Duijn PhD 24 , Mary F. Feitosa PhD 25 , Christopher J. O'Donnell MD, PhD 142 , Mika Kähönen MD, PhD 143,144 , Markus Perola MD, PhD 29,30 , Michael Boehnke MD, PhD 145 , Sharon L. Kardia PhD 32 , Jeanette Erdmann PhD 146,